(VIANEWS) – BP (BP), Sonos (SONO), UMB Financial Corporation (UMBF) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. BP (BP)

91.6% sales growth and 9.64% return on equity

BP PLC is involved in energy worldwide.

BP’s sales growth this year is anticipated to be 59.5% and a negative 7.9% for next year.

Year-on-year quarterly revenue growth grew by 83%, now sitting on 156.79B for the twelve trailing months.

Volume

Today’s last reported volume for BP is 8439020 which is 34.83% below its average volume of 12949600.

BP’s sales growth for the next quarter is 91.6%. The company’s growth estimates for the ongoing quarter and the next is 95.2% and 58.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.64%.

Volatility

BP’s last day, last week, and last month’s current intraday variation average was 2.46%, 2.06%, and 2.28%, respectively.

BP’s highest amplitude of average volatility was 1.67% (day), 2.06% (last week), and 2.81% (last month), respectively.

BP’s Stock Yearly Top and Bottom Value

BP’s stock is valued at $26.60 at 16:22 EST, way below its 52-week high of $34.30 and way higher than its 52-week low of $22.64.

BP’s Moving Average

BP’s worth is way under its 50-day moving average of $30.47 and under its 200-day moving average of $29.45.

2. Sonos (SONO)

31.6% sales growth and 22.56% return on equity

Sonos, Inc., along with its affiliates, design, develop, manufacture, and market multi-room audio products throughout the Americas, Europe, Africa, Middle East, Africa, Asia Pacific, and Asia.

Sonos’s sales growth this year is anticipated to be 14.4% and 8.6% for next year.

Year-on-year quarterly revenue growth grew by 20.1%, now sitting on 1.8B for the twelve trailing months.

Volume

Today’s last reported volume for Sonos is 1935820 which is 29.44% below its average volume of 2743780.

Sonos’s sales growth is a negative 0% for the present quarter and 31.6% for the next. The company’s growth estimates for the present quarter and the next is a negative 41.7% and 271.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.56%.

Volatility

Sonos’s last day, last week, and last month’s current intraday variation average was 0.67%, 2.57%, and 2.55%, respectively.

Sonos’s highest amplitude of average volatility was 4.52% (day), 4.32% (last week), and 4.59% (last month), respectively.

Sonos’s Stock Yearly Top and Bottom Value

Sonos’s stock is valued at $17.92 at 16:22 EST, way below its 52-week high of $42.57 and higher than its 52-week low of $17.68.

Sonos’s Moving Average

Sonos’s worth is way below its 50-day moving average of $21.22 and way below its 200-day moving average of $27.40.

3. UMB Financial Corporation (UMBF)

18% sales growth and 12.84% return on equity

UMB Financial Corporation is the bank holding firm for UMB Bank, which provides various financial services.

UMB Financial Corporation’s sales growth this year is expected to be 10.1% and 6.6% for next year.

Year-on-year quarterly revenue growth grew by 9.7%, now sitting on 1.29B for the twelve trailing months.

Volume

Today’s last reported volume for UMB Financial Corporation is 195393 which is 11.12% below its average volume of 219842.

UMB Financial Corporation’s sales growth for the next quarter is 18%. The company’s growth estimates for the current quarter and the next is a negative 0% and negative 0%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.84%.

Volatility

UMB Financial Corporation’s last day, last week, and last month’s current intraday variation average was 1.51%, 1.01%, and 1.16%, respectively.

UMB Financial Corporation’s highest amplitude of average volatility was 2.06% (day), 1.79% (last week), and 2.66% (last month), respectively.

UMB Financial Corporation’s Stock Yearly Top and Bottom Value

UMB Financial Corporation’s stock is valued at $86.84 at 16:22 EST, way below its 52-week high of $112.24 and above its 52-week low of $81.57.

UMB Financial Corporation’s Moving Average

UMB Financial Corporation’s worth is under its 50-day moving average of $88.59 and way under its 200-day moving average of $98.15.

4. Ryder System (R)

15.7% sales growth and 26.21% return on equity

Ryder System, Inc. offers transportation and supply chain management services worldwide.

Ryder System’s sales growth this year is anticipated to be 19.3% and 4.6% for next year.

Year-on-year quarterly revenue growth grew by 28.5%, now sitting on 10.3B for the twelve trailing months.

Volume

Today’s last reported volume for Ryder System is 242614 which is 72.35% below its average volume of 877491.

Ryder System’s sales growth for the next quarter is 15.7%. The company’s growth estimates for the current quarter and the next is 54.6% and 29.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 26.21%.

Volatility

Ryder System’s last day, last week, and last month’s current intraday variation average was 0.03%, 1.47%, and 1.60%, respectively.

Ryder System’s highest amplitude of average volatility was 2.04% (day), 3.01% (last week), and 3.22% (last month), respectively.

Ryder System’s Stock Yearly Top and Bottom Value

Ryder System’s stock is valued at $72.35 at 16:22 EST, way under its 52-week high of $93.05 and way above its 52-week low of $61.71.

Ryder System’s Moving Average

Ryder System’s worth is below its 50-day moving average of $75.46 and below its 200-day moving average of $78.37.

5. John Bean Technologies Corporation (JBT)

14.8% sales growth and 16.08% return on equity

John Bean Technologies Corporation offers technology solutions for the food and beverage industries as well as equipment and services for air transport.

John Bean Technologies Corporation’s sales growth this year is expected to be 17.6% and 8% for next year.

Year-on-year quarterly revenue growth grew by 12.3%, now sitting on 1.92B for the twelve trailing months.

Volume

Today’s last reported volume for John Bean Technologies Corporation is 5976 which is 97.12% below its average volume of 208185.

John Bean Technologies Corporation’s sales growth for the next quarter is 14.8%. The company’s growth estimates for the ongoing quarter and the next is 0.8% and 38.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.08%.

Volatility

John Bean Technologies Corporation’s last day, last week, and last month’s current intraday variation average was 1.16%, 1.33%, and 1.95%, respectively.

John Bean Technologies Corporation’s highest amplitude of average volatility was 3.27% (day), 3.96% (last week), and 3.53% (last month), respectively.

John Bean Technologies Corporation’s Stock Yearly Top and Bottom Value

John Bean Technologies Corporation’s stock is valued at $110.19 at 16:22 EST, way below its 52-week high of $177.56 and way above its 52-week low of $98.57.

John Bean Technologies Corporation’s Moving Average

John Bean Technologies Corporation’s worth is below its 50-day moving average of $115.55 and way under its 200-day moving average of $133.89.

6. Camelot Capital Partners, LLC (BBD)

14.6% sales growth and 15.78% return on equity

Camelot Capital Partners, LLC’s sales growth this year is expected to be 6.5% and 5.8% for next year.

Year-on-year quarterly revenue growth grew by 0.6%, now sitting on 92.84B for the twelve trailing months.

Volume

Today’s last reported volume for Camelot Capital Partners, LLC is 25351800 which is 29.82% below its average volume of 36124900.

Camelot Capital Partners, LLC’s sales growth for the next quarter is 14.6%. The company’s growth estimates for the ongoing quarter and the next is 18.2% and 9.1%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.78%.

Volatility

Camelot Capital Partners, LLC’s last day, last week, and last month’s current intraday variation average was 2.37%, 2.44%, and 2.00%, respectively.

Camelot Capital Partners, LLC’s highest amplitude of average volatility was 3.89% (day), 3.65% (last week), and 3.18% (last month), respectively.

Camelot Capital Partners, LLC’s Stock Yearly Top and Bottom Value

Camelot Capital Partners, LLC’s stock is valued at $3.02 at 16:22 EST, under its 52-week low of $3.07.

Camelot Capital Partners, LLC’s Moving Average

Camelot Capital Partners, LLC’s worth is way under its 50-day moving average of $3.70 and way below its 200-day moving average of $3.84.

7. Vir Biotechnology (VIR)

8% sales growth and 91.71% return on equity

Vir Biotechnology, Inc., a company in clinical immunology, creates treatments to prevent and treat serious infections.

Vir Biotechnology’s sales growth this year is expected to be 39.2% and a negative 70.8% for next year.

Year-on-year quarterly revenue growth grew by 62271.4%, now sitting on 2.33B for the twelve trailing months.

Volume

Today’s last reported volume for Vir Biotechnology is 936619 which is 16.63% below its average volume of 1123540.

Vir Biotechnology’s sales growth is a negative 0% for the present quarter and 8% for the next. The company’s growth estimates for the current quarter and the next is a negative 60.9% and negative -172%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 91.71%.

Volatility

Vir Biotechnology’s last day, last week, and last month’s current intraday variation average was 1.57%, 3.13%, and 3.41%, respectively.

Vir Biotechnology’s highest amplitude of average volatility was 4.25% (day), 5.76% (last week), and 5.65% (last month), respectively.

Vir Biotechnology’s Stock Yearly Top and Bottom Value

Vir Biotechnology’s stock is valued at $25.87 at 16:22 EST, way under its 52-week high of $58.00 and way above its 52-week low of $18.21.

Vir Biotechnology’s Moving Average

Vir Biotechnology’s value is way higher than its 50-day moving average of $23.46 and way below its 200-day moving average of $31.68.

LEAVE A REPLY

Please enter your comment!
Please enter your name here